MesenchymAl stromal cells for Traumatic bRain Injury (MATRIx): a study protocol for a multicenter, double-blind, randomised, placebo-controlled phase II trial

Traumatic brain injury (TBI) is a significant cause of death and disability, with no effective neuroprotective drugs currently available for its treatment. Mesenchymal stromal cell (MSC)-based therapy shows pr...

Source: Intensive Care Medicine Experimental - August 25, 2023 Category: Surgery Authors: Elisa R. Zanier, Francesca Pischiutta, Eliana Rulli, Alessia Vargiolu, Francesca Elli, Paolo Gritti, Giuseppe Gaipa, Daniela Belotti, Gianpaolo Basso, Tommaso Zoerle, Nino Stocchetti and Giuseppe Citerio Tags: Methodologies Source Type: research